CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-23 | COLLIER EARL M JR Director | Option exercise · Stock Option (Right to Buy) | −30,000 | 53,000 | ||
| 2024-04-23 | Musket David B Director | Option exercise | +16,156 | $1.39 | $22K | 47,692 |
| 2024-04-23 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −856 | 0 | ||
| 2024-04-23 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −2,750 | 0 | ||
| 2024-04-23 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −1,050 | 0 | ||
| 2024-04-23 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −2,750 | 0 | ||
| 2024-04-23 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2024-04-23 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −5,750 | 0 | ||
| 2024-01-02 | Kelliher Mike Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | Kelliher Mike Director | Grant or award · Stock Option (Right to Buy) | +890 | 890 | ||
| 2024-01-02 | Kelliher Mike Director | Grant or award · Stock Option (Right to Buy) | +4,730 | 4,730 | ||
| 2024-01-02 | Kelliher Mike Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-01-02 | Gotwals Philip J Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | Gotwals Philip J Director | Grant or award · Stock Option (Right to Buy) | +1,330 | 1,330 | ||
| 2024-01-02 | Gotwals Philip J Director | Grant or award · Stock Option (Right to Buy) | +6,370 | 6,370 | ||
| 2024-01-02 | Auwaerter Paul Gisbert Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | Auwaerter Paul Gisbert Director | Grant or award · Stock Option (Right to Buy) | +890 | 890 | ||
| 2024-01-02 | Auwaerter Paul Gisbert Director | Grant or award · Stock Option (Right to Buy) | +6,760 | 6,760 | ||
| 2024-01-02 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +4,460 | 4,460 |
Page 7 of 24 · 468 trades